Clevidipine Patent Expiration
Clevidipine is Used for lowering blood pressure when oral therapy is not feasible or not desirable. It was first introduced by Chiesi Usa Inc
Clevidipine Patents
Given below is the list of patents protecting Clevidipine, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Cleviprex | US10010537 | Clevidipine emulsion formulations containing antimicrobial agents | Oct 10, 2031 | Chiesi |
| Cleviprex | US11103490 | Clevidipine emulsion formulations containing antimicrobial agents | Oct 10, 2031 | Chiesi |
| Cleviprex | US8658676 | Clevidipine emulsion formulations containing antimicrobial agents | Oct 10, 2031 | Chiesi |
| Cleviprex | US5856346 | Short-acting dihydropyridines |
Jan 05, 2021
(Expired) | Chiesi |
| Cleviprex | US5856346 | Short-acting dihydropyridines |
Jan 05, 2021
(Expired) | Chiesi |
| Cleviprex | US5739152 | Pharmaceutical emulsion |
Apr 14, 2015
(Expired) | Chiesi |
Clevidipine's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List